Simeon George

Director, Genocea (United States).

Companies

ADARx Pharmaceuticals, Inc.Board member Sep 24, 2026 to now¹
Design Therapeutics, Inc.Board member Mar 25, 2021 to now²
Nkarta Therapeutics (United States)Board member Jul 9, 2020 to now³
CRISPR TherapeuticsBoard member Oct 18, 2016 to now⁴
Turning Point Therapeutics, Inc.Board member Apr 16, 2019 to Aug 17, 2022⁵
Principia Biopharma (United States)Board member Sep 13, 2018 to Sep 28, 2020⁶
HTG MOLECULAR DIAGNOSTICS, INCBoard member May 5, 2015 to May 5, 2015⁷
Genocea (United States)Board member Feb 4, 2014 to Feb 11, 2014⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CRISPR Therapeutics CRSP1,730,179 shares⁹$86.4M at $49.91Jul 16, 2025
Design Therapeutics, Inc. DSGN6,526,476 shares¹⁰$70.9M at $10.87Dec 20, 2022
ADARx Pharmaceuticals, Inc. ADRX592,593 shares¹¹$10.5M at $17.71Sep 28, 2026
Nkarta Therapeutics (United States) NKTX666,666 shares¹²$1.2M at $1.78Mar 28, 2024
Turning Point Therapeutics, Inc.0 shares¹³Aug 17, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 28, 2026Bought 592,593 shares at $17.00 of ADARx Pharmaceuticals, Inc.¹¹
Sep 28, 2026Converted 169,001 shares of ADARx Pharmaceuticals, Inc.¹¹
Sep 28, 2026Converted 1,667,468 shares of ADARx Pharmaceuticals, Inc.¹¹
Sep 28, 2026Bought 414,814 shares at $17.00 of ADARx Pharmaceuticals, Inc.¹¹
Sep 28, 2026Converted 1,538,691 shares of ADARx Pharmaceuticals, Inc.¹¹
Sep 28, 2026Bought 592,593 shares at $17.00 of ADARx Pharmaceuticals, Inc.¹¹
Sep 28, 2026Converted 512,897 shares of ADARx Pharmaceuticals, Inc.¹¹
Sep 28, 2026Converted 1,113,666 shares of ADARx Pharmaceuticals, Inc.¹¹
Sep 28, 2026Converted 3,334,938 shares of ADARx Pharmaceuticals, Inc.¹¹
May 11, 2026Bought 200,000 shares at $18.00 of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Sold 438 shares at $18.00 of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Exercised 78,656 shares of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Converted 273,527 shares of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Converted 463,106 shares of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Bought 133,333 shares at $18.00 of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Sold 277 shares at $18.00 of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Exercised 49,850 shares of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Converted 166,168 shares of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Converted 20,582 shares of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Converted 204,658 shares of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Converted 255,823 shares of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Converted 118,512 shares of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Bought 222,222 shares at $18.00 of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Sold 1,065 shares at $18.00 of Odyssey Therapeutics, Inc.¹⁴
May 11, 2026Exercised 191,541 shares of Odyssey Therapeutics, Inc.¹⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARADARx Pharmaceuticals, Inc., Board member
2
SEC EDGARDesign Therapeutics, Inc., Board member
3
SEC EDGARNkarta Therapeutics (United States), Board member
4
SEC EDGARCRISPR Therapeutics, Board member
5
SEC EDGARTurning Point Therapeutics, Inc., Board member
6
SEC EDGARPrincipia Biopharma (United States), Board member
7
SEC EDGARHTG MOLECULAR DIAGNOSTICS, INC, Board member
8
SEC EDGARGenocea (United States), Board member
9
SEC EDGARCRISPR Therapeutics shares after the filing of Jul 16, 2025
10
SEC EDGARDesign Therapeutics, Inc. shares after the filing of Dec 20, 2022
11
SEC EDGARADARx Pharmaceuticals, Inc. shares after the filing of Sep 28, 2026
12
SEC EDGARNkarta Therapeutics (United States) shares after the filing of Mar 28, 2024
13
SEC EDGARTurning Point Therapeutics, Inc. shares after the filing of Aug 17, 2022
14
SEC EDGARForm 4 filed May 11, 2026